Oaktree Acquisition Corp. III Life Sciences (OACCW) Current Assets (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences' Current Assets history runs 3 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• Quarterly Current Assets fell 4.47% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 4.47% YoY) and the FY2025 annual result came in at $1.5 million, down 0.65% from the prior year.
• Current Assets was $1.4 million for Q1 2026 at Oaktree Acquisition Corp. III Life Sciences, down from $1.5 million in the prior quarter.
• Across five years, Current Assets topped out at $1.6 million in Q2 2025 and bottomed at $1.4 million in Q1 2026.
• A 3-year average of $1.5 million and a median of $1.5 million in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2025 — Current Assets decreased 0.65% — and 2026, when it dropped 4.47%.
• Oaktree Acquisition Corp. III Life Sciences' Current Assets stood at $1.6 million in 2024, then fell by 0.65% to $1.5 million in 2025, then declined by 8.53% to $1.4 million in 2026.
• Business Quant data shows OACCW's Current Assets at $1.4 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.